Literature DB >> 25375416

In Vitro Assessment of Human Islet Vulnerability to Instant Blood-Mediated Inflammatory Reaction (IBMIR) and Its Use to Demonstrate a Beneficial Effect of Tissue Culture.

Raina D Ramnath1, Elisa Maillard, Katherine Jones, Paul A Bateman, Stephen S J Hughes, Jane Gralla, Paul R Johnson, Derek W R Gray.   

Abstract

Culture of human pancreatic islets is now routinely carried out prior to clinical islet allotransplantation, using conditions that have been developed empirically. One of the major causes of early islet destruction after transplantation is the process termed instant blood-mediated inflammatory reaction (IBMIR). The aim of this study was to develop in vitro methods to investigate IBMIR and apply them to the culture conditions used routinely in our human islet isolation laboratory. Freshly isolated or precultured (24 h, 48 h) human islets were incubated in either ABO-compatible allogeneic human blood or Hank's buffered salt solution (HBSS) for 1 h at 37°C. Tissue factor (TF) expression and leukocyte migration were assessed by light microscopy. TF was also quantified by ELISA. To assess β-cell function, glucose-stimulated insulin secretion (GSIS) assay was carried out. The extent of islet β-cell damage was quantified using a proinsulin assay. Islets cultured for 24 h had higher GSIS when compared to freshly isolated or 48-h precultured islets. Freshly isolated islets had significantly higher TF content than 24-h and 48-h precultured islets. Incubation of freshly isolated human islets in allogeneic human blood released 6.5-fold higher level of proinsulin in comparison to freshly isolated human islets in HBSS. The high level of proinsulin released was significantly attenuated when precultured islets (24 h or 48 h) were exposed to fresh blood. Histological examination of fresh islets in blood clot showed that some islets were fragmented, showing signs of extraislet insulin leakage and extensive neutrophil infiltration and necrosis. These features were markedly reduced when the islets were cultured for 24 h. These results suggest that our standard 24-h islet culture is markedly beneficial in attenuating IBMIR, as evidenced by increased GSIS, lower content of TF, decrease islet fragmentation, and proinsulin release.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25375416     DOI: 10.3727/096368914X685320

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

Review 1.  A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts.

Authors:  Thomas Pomposelli; Christian Schuetz; Ping Wang; Kazuhiko Yamada
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 6.055

2.  Impact of Pancreatic Rat Islet Density on Cell Survival during Hypoxia.

Authors:  A Rodriguez-Brotons; W Bietiger; C Peronet; J Magisson; C Sookhareea; A Langlois; C Mura; N Jeandidier; M Pinget; S Sigrist; E Maillard
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

Review 3.  Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells.

Authors:  Nadine E Rekittke; Meidjie Ang; Divya Rawat; Rahul Khatri; Thomas Linn
Journal:  Stem Cells Int       Date:  2016-03-07       Impact factor: 5.443

4.  Improvement of islet graft function using liraglutide is correlated with its anti-inflammatory properties.

Authors:  A Langlois; S Dal; K Vivot; C Mura; E Seyfritz; W Bietiger; C Dollinger; C Peronet; E Maillard; M Pinget; N Jeandidier; S Sigrist
Journal:  Br J Pharmacol       Date:  2016-11-06       Impact factor: 8.739

5.  Protection of Pancreatic Islets Using Theranostic Silencing Nanoparticles in a Baboon Model of Islet Transplantation.

Authors:  Thomas Pomposelli; Ping Wang; Kazuhiro Takeuchi; Katsunori Miyake; Yuichi Ariyoshi; Hironosuke Watanabe; Xiaojuan Chen; Akira Shimizu; Neil Robertson; Kazuhiko Yamada; Anna Moore
Journal:  Diabetes       Date:  2020-08-27       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.